Olivetti L, Grazioli L, Maroldi R, Matricardi L, Milanesio L
Cattedra di Radiologia, Università, Spedali Civili, Brescia.
Radiol Med. 1992 Apr;83(4):353-60.
Thirty-five patients with hepatic hemangioma (n = 12), metastasis (n = 10), hepatocellular carcinoma (HCC) (n = 10) and focal nodular hyperplasia (n = 3) were examined with the fast low-angle shot (FLASH) technique and an intravenous bolus injection of Gd-DTPA. In order to differentiate the lesions, the following criteria were used: a) pre Gd-DTPA intensity of lesions; b) post Gd-DTPA patterns of contrast enhancement. On the basis of these criteria, an unquestionable differential diagnosis could be made. Hemangiomas were characterized by an hypointense mass before Gd-DTPA, by peripheral contrast enhancement and by subsequent continuous hyperintense fill-in; thus, hemangiomas were visualized as hyperintense lesion during the late phase. Before contrast administration hypovascular metastases appeared as hypointense; they were characterized by delayed uptake of contrast agent. HCCs were hyperintense lesions before contrast administrations; then, quick contrast enhancement and rapid decrease in signal intensity were observed with visualization of a hyperintense ring due to the capsule. Finally, focal nodular hyperplasia appeared isointense or hypointense relative to normal liver on precontrast scans; the lesions were enhanced transiently with subsequent quick dismission of contrast agent. This initial experience suggests dynamic contrast-enhanced MR imaging as an effective method to improve the differential diagnosis among hepatic tumors when precontrast T2-weighted images are equivocal.
35例患有肝血管瘤(n = 12)、转移瘤(n = 10)、肝细胞癌(HCC)(n = 10)和局灶性结节性增生(n = 3)的患者接受了快速低角度激发(FLASH)技术检查,并静脉推注钆喷酸葡胺(Gd-DTPA)。为了鉴别这些病变,采用了以下标准:a)病变在注射Gd-DTPA前的信号强度;b)注射Gd-DTPA后的对比增强模式。基于这些标准,可以做出明确的鉴别诊断。肝血管瘤的特征是在注射Gd-DTPA前为低信号肿块,周边对比增强,随后持续填充为高信号;因此,肝血管瘤在延迟期表现为高信号病变。在注射对比剂前,乏血供转移瘤表现为低信号;其特征是对比剂延迟摄取。肝细胞癌在注射对比剂前为高信号病变;然后,观察到快速对比增强和信号强度迅速降低,并可见由于包膜形成的高信号环。最后,局灶性结节性增生在注射对比剂前相对于正常肝脏呈等信号或低信号;病变呈短暂性增强,随后对比剂迅速消退。这一初步经验表明,当注射对比剂前的T2加权图像不明确时,动态对比增强磁共振成像作为一种有效的方法可用于改善肝肿瘤的鉴别诊断。